Turtle Cameron
CIK 1758363
Transactions on file
25
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 400 | $35.6K | -0.1% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,700 | $325.8K | +1.0% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 8,400 | $732.1K | +2.1% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 2,500 | $215.9K | +3.0% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 16 | $1.6K | -8.7% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,392 | $134.8K | -8.1% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 5,635 | $540.6K | -7.2% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 7,157 | $680.6K | -6.4% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 800 | $75.2K | -5.3% | open → |
| 2026-07-05 | 2026-07-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 590 | $52.5K | +0.1% | open → |
| 2026-07-05 | 2026-07-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 4,234 | $373.1K | +1.0% | open → |
| 2026-07-05 | 2026-07-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 10,176 | $889.8K | +1.8% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,294 | $235.1K | +24.7% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 8,149 | $574.5K | +26.2% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,557 | $246.9K | +28.2% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 300 | $22.5K | +18.7% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,700 | $126.2K | +19.9% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,100 | $226.7K | +21.7% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,000 | $71.8K | +24.0% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,600 | $254.8K | +25.7% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 5,300 | $368.6K | +28.0% | open → |
| 2025-12-03 | 2025-12-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 4,005 | $119.5K | +198.3% | open → |
| 2025-12-03 | 2025-12-01 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 10,995 | $315.9K | +209.7% | open → |
| 2025-11-05 | 2025-11-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 16,845 | $398.6K | +276.1% | open → |
| 2025-11-05 | 2025-11-03 | SYRE Spyre Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 28,155 | $651.2K | +284.7% | open → |
